StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
HBIO

Harvard Bioscience, Inc.

HBIO Nasdaq Laboratory Analytical Instruments EDGAR ↗
$6.31
+0.21 +3.44%

Key statistics

from XBRL data in SEC filings
Market cap
$28.5M
Revenue (TTM)
$85.5M
Net income (TTM)
-$9.78M
EPS (TTM)
$9.37
P/E ratio
0.7
Dividend yield
Free cash flow
$5.47M
Cash
$7.10M
Total assets
$77.9M
Gross margin
58.4%
52-week range
$3.80 – $9.40

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Regulation FD disclosure May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Regulation FD disclosure Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Director or officer change Mar 10, 2026 8-K Shareholder vote results; Regulation FD disclosure; Other events Mar 6, 2026 8-K Results of operations (earnings release) Feb 10, 2026 8-K Exit or disposal costs; Regulation FD disclosure Jan 29, 2026 8-K Amended charter or bylaws Jan 20, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Director or officer change Dec 17, 2025 8-K Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Delisting notice or listing-rule failure Oct 3, 2025 8-K Director or officer change; Regulation FD disclosure Sep 9, 2025 8-K Director or officer change Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Entered a material agreement Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Director or officer change; Other events Jul 17, 2025 8-K/A Delisting notice or listing-rule failure Jun 27, 2025 8-K Delisting notice or listing-rule failure Jun 23, 2025 8-K Director or officer change Jun 13, 2025 8-K Director or officer change; Shareholder vote results Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change Apr 16, 2025 8-K Delisting notice or listing-rule failure; Director or officer change; Other events Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 14, 2025 8-K Results of operations (earnings release) Mar 12, 2025 8-K Entered a material agreement; Other events Mar 12, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results May 14, 2024